Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

Acquisition

17 Nov 2015 07:01

RNS Number : 9022F
Renold PLC
17 November 2015
 

Renold plc

("Renold", "the Company" or "the Group")

 

Proposed acquisition of Aventics TC ("the Acquisition")

Renold, a leading international supplier of industrial chains and related power transmission products, is pleased to announce that it has signed a conditional sale and purchase agreement to acquire the business and trading assets of Aventics Tooth Chain ("Aventics TC"), an operating division of Aventics Gmbh based in Germany, for up to €6.3 million (£4.5 million) in cash.

 

The consideration (on a cash and debt free basis) will be satisfied by an initial payment of €4.8 million at completion followed by further expected payments of up to €1.5 million over the two year period following completion, contingent on achieving certain sales targets. All payments will be satisfied from the Group's existing banking facilities. Completion of the Acquisition is expected to occur after the statutory 'TUPE' consultation period with the employees in Germany and after certain carve out activities have been completed to separate the business from Aventics.

 

As a division of Aventics Gmbh, Aventics TC does not prepare separate audited accounts. Based on financial information obtained by Renold during the due diligence process, third-party sales in the year to 31 December 2014 were €7.5 million (£5.3 million). In addition, approximately €1.5 million (£1.0 million) of sales were delivered indirectly via other Aventics group companies and plans are in place to transition this indirect business to Renold as part of the post closing process. On a proforma basis, Aventics TC made an operating profit before exceptional items of €1.1 million (£0.8 million) in the year ended 31 December 2014. Gross assets at that date were €1.7 million (£1.2 million).

 

Renold anticipates that the Acquisition will be broadly neutral for adjusted earnings in the current financial year, as a result of the business separation costs to be incurred, but should be earnings enhancing thereafter. The Acquisition constitutes a Class 2 transaction for the purposes of the UK Financial Authority's Listing Rules and, as such, does not require Renold shareholders' approval.

 

Aventics TC

Aventics TC is the market leader in the manufacture of inverted tooth chain for industrial applications. Tooth chain is a specialist product not currently manufactured by Renold and is typically seen in applications such as bottling plants and other manufacturing facilities and equipment. The business employs 65 people and operates from a self-contained rented facility in Gronau, Lower Saxony with its own dedicated manufacturing, engineering and sales teams. Two thirds of Aventics TC sales are currently made in Germany with the balance of sales being made in a wide range of international territories including other western European countries, the USA and China. The business operates as a niche division of Aventics Gmbh which specialises in pneumatics equipment and shares certain sales and back office processes with the Aventics Group as a whole.

 

Benefits of the acquisition

Through the Acquisition of Aventics TC, Renold will gain access to a high value-added product not currently part of the Renold offering. Renold expects to expand sales through the existing Renold global sales presence and network which will allow access to a much wider geographical market than currently. In addition, as the factory is close to Renold's plant in Einbeck, Germany, the business will be able to share expertise and some infrastructure services within the more substantial Renold Group.

 

Robert Purcell, Chief Executive of Renold, said:

"The purchase of Aventics TC is an excellent fit with Phase 3 of our STEP 2020 Strategic Plan (the 'Acquisitions' Phase). Aventics TC manufactures a specialist, high quality product which will expand our existing product offering whilst Renold's international footprint will, over time, give the Tooth Chain business access to new customers and geographies."

 

17 November 2015

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

Brian Tenner, Finance Director

Arden Partners

020 7614 5917

Chris Hardie

Instinctif Partners

020 7457 2020

Mark Garraway

Helen Tarbet

 

 

 

 

 

 

 

 

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUNVNRVRAAAAA
Date   Source Headline
12th Jul 20237:00 amRNSResults for the year ended 31 March 2023
10th Jul 20237:00 amRNSInvestor Presentation
19th Jun 20239:30 amRNSBlock Listing Six Monthly Return
18th May 20237:00 amRNSPreference Stock Dividend
9th May 20237:00 amRNSExtension of banking facilities
3rd May 202311:09 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update and Notice of Results
28th Mar 202312:53 pmRNSHolding(s) in Company
9th Mar 20237:00 amRNSNotice of Capital Markets Day
23rd Feb 202312:09 pmRNSHolding(s) in Company
10th Feb 20232:07 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSTrading Update
25th Jan 202310:00 amRNSHolding(s) in Company
24th Jan 20233:09 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSContract Win
19th Dec 20227:00 amRNSBlock Listing Six Monthly Return
8th Dec 20227:00 amRNSHolding(s) in Company
24th Nov 20225:18 pmRNSPreference Stock Dividend
16th Nov 20227:00 amRNSInterim Results
3rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
12th Oct 20229:12 amRNSHolding(s) in Company
5th Oct 20224:10 pmRNSHolding(s) in Company
20th Sep 202212:34 pmRNSGrant of Options
9th Sep 202211:37 amRNSDirector/PDMR Shareholding
6th Sep 202212:13 pmRNSResult of AGM
6th Sep 20227:00 amRNSAGM Trading Update
4th Aug 20227:30 amRNS2022 Annual Report & Notice of AGM
4th Aug 20227:00 amRNSAcquisition of Industrias YUK S.A.
13th Jul 20227:00 amRNSFinal results for the year ended 31 March 2022
8th Jul 20227:00 amRNSInvestor presentation
17th Jun 20227:00 amRNSBlock Listing Six Monthly Return
18th May 202212:18 pmRNSPreference Stock Dividend
4th May 20227:00 amRNSAppointment of Non-Executive Director
19th Apr 20223:53 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Update and Notice of Results
2nd Feb 20224:35 pmRNSPrice Monitoring Extension
25th Jan 20229:23 amRNSHolding(s) in Company
20th Jan 20224:42 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
20th Dec 202111:10 amRNSHolding(s) in Company
17th Dec 20218:43 amRNSBlock Listing Six Monthly Return
29th Nov 20213:15 pmRNSHolding(s) in Company
10th Nov 20217:00 amRNSInterim Results
8th Nov 20217:00 amRNSPreference Stock Dividend
5th Nov 20217:00 amRNSAppointment of Joint Broker
2nd Nov 202111:07 amRNSHolding(s) in Company
1st Nov 20211:04 pmRNSHolding(s) in Company
27th Oct 20217:00 amRNSNotice of Interim Results
20th Oct 20213:48 pmRNSHolding(s) in Company
31st Aug 202111:50 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.